AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.

We’re using evolution to attack tumors,” said study senior author, Ashish H. Shah, M.D. Viral mimicry was first successfully used to make ovarian cancer more susceptible to ICI in 2015. It has since ...

Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...

As Colorectal Cancer Awareness Month highlights the importance of early detection and advancements in treatment, according to ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

Jessica Wozniak thought that some of the symptoms of norovirus were lingering. They were signs of Stage 4 colon cancer.

In a groundbreaking moment for cancer, Chinese researchers turned the immune response provoked by organ transplants to fight ...